Subscribe to Newsletter
Subspecialties Imaging & Diagnostics, Cornea / Ocular Surface, Business and Innovation, Practice Management

Targeted Gene Testing

sponsored by Avellino

We are in a golden age of science, with tremendous leaps being made particularly in genomics. And it is now possible for the ophthalmology community to leverage the power and promise of genetic information to benefit patients.

AvaGenTM from Avellino is the first genetic test that quantifies the genetic risk of keratoconus and presence of TGFBI related corneal dystrophies. It uses nextgeneration sequencing (NGS) to target both the 75 genes and more than 2,000 variants associated with keratoconus, while also targeting 70 variants of the TGFBI gene for stromal corneal dystrophies. 

As keratoconus is a debilitating genetic disease that is often misdiagnosed, AvaGen is an important step ophthalmologists can take to diagnose the condition earlier, which can make a significant difference toward preserving vision over a lifetime. 

AvaGen empowers more confident patient management by providing a polygenic risk score (PRS) for keratoconus, and a “yes” or “no” indication for corneal dystrophies. The results can help rule patients “in” or “out” for refractive surgery; identify the genetic risk of disease among family members; and help inform patients with suspect topographies or progressive vision changes.

The patient sample is taken via a simple cheek swab and processed in Avellino’s CLIAcertified lab. The results are available to the doctor via a HIPAA-compliant portal and complimentary genetic counseling is available.

Avellino expects to expand AvaGen in 2022 to test for additional ocular diseases with a broadened panel, as well as offering a genetic test for Fuchs’ dystrophy and glaucoma.

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Related Case Studies
Business & Profession Glaucoma
TrabEx Pro: The Next Level in MIGS

| Contributed by MST

The Missing Piece of the Dry Eye Puzzle

| Contributed by Quidel

Uncovering Ocular Comorbidity

| Contributed by Quidel

Related Product Profiles
Uncover the Unique DNA of SPECTRALIS®

| Contributed by Heidelberg Engineering

Subspecialties Cornea / Ocular Surface
Tear Osmolarity – Empowering. Established. Essential.

| Contributed by TearLab

Subspecialties Retina
ForeseeHome® – remote monitoring to help detect wet AMD earlier and improve outcomes

| Contributed by Notal Vision

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Most Popular
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine



The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: